| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014917982 |
| P356 | DOI | 10.1007/S11897-014-0248-Y |
| P698 | PubMed publication ID | 25542216 |
| P50 | author | Javed Butler | Q63107356 |
| P2093 | author name string | Divya Gupta | |
| Alanna A Morris | |||
| Robert T Cole | |||
| P2860 | cites work | The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial | Q44532842 |
| Safety of spironolactone use in ambulatory heart failure patients | Q46249441 | ||
| Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit | Q46318699 | ||
| A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease | Q48439401 | ||
| Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). | Q51308304 | ||
| Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport | Q67987269 | ||
| Managing patients with cardiorenal syndrome: time to look to the gut? | Q84466761 | ||
| Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist | Q87842853 | ||
| 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q22306358 | ||
| 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines | Q26864648 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Hormones and hemodynamics in heart failure | Q33713907 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
| Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial | Q34751971 | ||
| The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis | Q34765075 | ||
| Diuretic strategies in patients with acute decompensated heart failure | Q36141962 | ||
| A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects | Q37518921 | ||
| Dietary sodium intake in heart failure | Q38028802 | ||
| Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. | Q40470495 | ||
| A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. | Q41862960 | ||
| Renal function as a predictor of outcome in a broad spectrum of patients with heart failure | Q43500856 | ||
| Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors | Q44188982 | ||
| Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | Q44272913 | ||
| Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study | Q44485270 | ||
| P433 | issue | 2 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 107-111 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Current heart failure reports | Q26842297 |
| P1476 | title | Oral sodium and potassium binders in heart failure | |
| P478 | volume | 12 |
Search more.